Showing results (51-60 of 279) with videos related to
Sort By:
Pageof 28
Physiological Genomics|July 9, 2009
Kininogen gene (KNG) variation has a consistent effect on aldosterone response to antihypertensive drug therapy: the GERA studyMaja Barbalic, Gary L Schwartz, Arlene B Chapman, et al.American Journal of Hypertension|April 18, 2013
The role of plasma renin activity, age, and race in selecting effective initial drug therapy for hypertensionGary L Schwartz, Kent Bailey, Arlene B Chapman, et al.Plos One|January 28, 2015
A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplicationTaimour Langaee, Issam Hamadeh, Arlene B Chapman, et al.Seminars in Nephrology|June 21, 2020
Quality Appraisal and Assurance Techniques for Free Open Access Medical Education (FOAM) Resources: A Rapid ReviewDaniel K Ting, Patrick Boreskie, S Luckett-Gatopoulos, et al.Canadian Journal of Gastroenterology & Hepatology|February 24, 2015
Examining the clinical use of hemochromatosis genetic testingMatthew B Lanktree, Bruce B Lanktree, Guillaume Paré, et al.Human Molecular Genetics|September 25, 2012
Gene-centric meta-analyses of 108 912 individuals confirm known body mass index loci and reveal three novel signalsYiran Guo, Matthew B Lanktree, Kira C Taylor, et al.Kidney International Reports|December 23, 2017
Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4Olivier Devuyst, Arlene B Chapman, Susan E Shoaf, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|December 4, 2002
Reproducibility of blood pressure response to hydrochlorothiazideJavier D Finkielman, Gary L Schwartz, Arlene B Chapman, et al.Journal of Clinical Pharmacology|February 21, 2017
Pharmacokinetics and Pharmacodynamics of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Phase 2 Trials for Dose Selection in the Pivotal Phase 3 TrialSusan E Shoaf, Arlene B Chapman, Vicente E Torres, et al.Kidney360|June 16, 2025
Transitional Care Units in the United States: A Model for Improving Dialysis CareLouis G Baeseman, Samantha Gunning, Bharathi V Reddy, et al.Pageof 28